Edgewise Therapeutics (EWTX) Non-cash Items (2021 - 2026)

Edgewise Therapeutics has disclosed Non-cash Items across 6 years of filings, most recently posting $1.1 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $1.1 million, down 14.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 14.84% YoY), and the FY2025 annual result was $1.1 million, down 75.06% from the prior year.
• Non-cash Items came in at $1.1 million for Q1 2026 at Edgewise Therapeutics, roughly flat from $1.1 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $4.6 million in Q4 2024 to a low of $1.1 million in Q4 2025.
• The 5-year median for Non-cash Items is $1.5 million (2023), against an average of $1.8 million.
• Across the five-year window, Non-cash Items sank 94.91% in 2022 and changed 0.0% in 2024, its largest moves.
• Edgewise Therapeutics' Non-cash Items stood at $3.9 million in 2022, then plunged by 60.75% to $1.5 million in 2023, then surged by 200.3% to $4.6 million in 2024, then tumbled by 75.06% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
• The last three Non-cash Items figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.